Frankfurt
05.06.26 | 08:00
8,000 Euro
-15,34 % -1,450
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Umsatz von LifeVantage bricht im ersten Quartal 2026 um 25,2 Prozent ein | 6 | Direct Selling Magazine | ||
| Mi | Small-cap food and personal care names see aggressive short positioning: VITL, BYND, LFVN | 27 | Seeking Alpha | ||
| LIFEVANTAGE Aktie jetzt für 0€ handeln | |||||
| Mo | Dividendenbekanntmachungen (01.06.2026) | 8.489 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCOR SA FR0000120404 - 1,35 EUR ACNB CORPORATION US0008681092 0,92 USD 0,7889 EUR AGNICO EAGLE MINES LIMITED CA0084741085 0,45... ► Artikel lesen | |
| 27.05. | Do Options Traders Know Something About LifeVantage Stock We Don't? | 3 | Zacks | ||
| 27.05. | Why Did LifeVantage (LFVN) Stock Jump 27% After Hours? | 5 | Benzinga.com | ||
| 12.05. | LifeVantage ernennt Terrence Moorehead zum Chief Executive Officer | 4 | Direct Selling Magazine | ||
| 07.05. | LifeVantage raises quarterly dividend by 11.1% to $0.05/share | 1 | Seeking Alpha | ||
| 07.05. | LifeVantage signals fiscal 2026 results near low end of guidance while raising quarterly dividend 11% to $0.05 | 1 | Seeking Alpha | ||
| 06.05. | LifeVantage Corporation: LifeVantage Declares Quarterly Dividend | 2 | GlobeNewswire (USA) | ||
| 06.05. | Lifevantage Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.05. | Lifevantage Corp - 8-K, Current Report | - | SEC Filings | ||
| 22.04. | LifeVantage Corporation: LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026 | 1 | GlobeNewswire (USA) | ||
| 21.04. | LifeVantage Corporation: LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack | 188 | GlobeNewswire (Europe) | SALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the... ► Artikel lesen | |
| 16.04. | LifeVantage appoints Moorehead as CEO, effective August | 2 | Seeking Alpha | ||
| 16.04. | LifeVantage ernennt Terrence Moorehead zum neuen CEO | 1 | Investing.com Deutsch | ||
| 16.04. | LifeVantage names Terrence Moorehead as new CEO | 2 | Investing.com | ||
| 16.04. | LifeVantage Corporation: LifeVantage Appointing Terrence Moorehead as Chief Executive Officer | 180 | GlobeNewswire (Europe) | SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate... ► Artikel lesen | |
| 16.04. | Lifevantage Corp - 8-K, Current Report | - | SEC Filings | ||
| 02.04. | LifeVantage kündigt Expansion nach Portugal für Mai 2026 an | 1 | Investing.com Deutsch | ||
| 02.04. | LifeVantage to expand into Portugal market in May | 2 | Investing.com |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 112,28 | +0,30 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| AURORA CANNABIS | 2,900 | -1,16 % | Aurora Deepens its Impact for Veterans Across Canada | ||
| ABBVIE | 197,15 | 0,00 % | Drei Qualitätswerte im Fokus: Was der "Quant Growth And Income"-Ansatz jetzt über Microsoft, Visa und AbbVie verrät | Microsoft, Visa und AbbVie stehen im Zentrum eines quantitativen Wachstums- und Einkommensansatzes, den Seeking Alpha aktuell transparent macht. Der Einblick in das "Quant Growth And Income"-Portfolio... ► Artikel lesen | |
| ELI LILLY | 982,20 | -0,05 % | Eli Lilly reports broad benefits for experimental obesity drug retatrutide | ||
| MERCK & CO | 105,12 | +0,19 % | Moderna, Inc.: Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting | At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurrence... ► Artikel lesen | |
| TEVA | 29,800 | +0,34 % | Teva Study Shows AUSTEDO Improves Quality Of Life In Huntington's Disease Chorea | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), has released new data from the first real-world, decentralized study evaluating... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 392,50 | +1,22 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on ALYFTREK at European Cystic Fibrosis Conference | - ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels... ► Artikel lesen | |
| CRONOS GROUP | 2,416 | +1,00 % | Cronos Group Inc.: Cronos Group Reports 2026 First Quarter Results | Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter... ► Artikel lesen | |
| VIATRIS | 13,794 | +0,15 % | Dividendenbekanntmachungen (22.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6712 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0645 EUR ADVANCED ENERGY INDUSTRIES... ► Artikel lesen | |
| EYEPOINT | 10,200 | 0,00 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| INCYTE | 88,66 | -0,23 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| BAUSCH HEALTH | 4,640 | 0,00 % | Bausch Health Companies Inc.: Bausch Health Announces 2026 Annual Meeting of Shareholder Results | LAVAL, QC, May 19, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that shareholders elected all 10 director nominees at its... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,947 | +2,38 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 64,10 | -0,80 % | H.C. Wainwright reiterates Ionis stock rating on hepatitis B data | ||
| SNDL | 1,250 | +1,79 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen |
Das Unternehmen LIFEVANTAGE CORPORATION kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 8,000 Euro und damit -15,34 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFEVANTAGE CORPORATION finden Sie auf Wallstreet Online.